Literature DB >> 3743703

Voluntary supraspinal suppression of spinal reflex activity in paralyzed muscles of spinal cord injury patients.

B Cioni, M R Dimitrijevic, W B McKay, A M Sherwood.   

Abstract

Having previously demonstrated that residual facilitatory brain influence on segmental structures occurs in paralyzed spinal cord injury patients, we sought evidence of suprasegmental suppression in such patients. By recording EMG activity from leg muscles, we studied changes in segmental excitability of the plantar reflex elicited by cutaneous stimulation of the plantar surface. Using surface EMG recordings, 50 paralyzed spinal cord injury patients were examined for their ability to volitionally suppress the plantar reflex on three repeated trials after three baseline trials. The patients, who had no voluntary EMG activity in the monitored muscles, were able to volitionally suppress the plantar reflex responses by 45% in the tibialis anterior, hamstring, and triceps surae muscles and to suppress the quadriceps response by 72%. In this patient group, 73 of 100 tibialis anterior muscle groups showed suppression of more than 20% compared with the control response. On reexamination, these findings were consistent during a period of 2 years in six patients. We conclude that suprasegmental suppression of segmental activity does occur in paralyzed spinal cord injury patients, and that in clinically complete patients, neurological evaluation should include assessment of the degree of preservation of suprasegmental neurocontrol on segmental activity below the lesion.

Entities:  

Mesh:

Year:  1986        PMID: 3743703     DOI: 10.1016/0014-4886(86)90177-9

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Interlimb reflexes following cervical spinal cord injury in man.

Authors:  B Calancie
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 2.  Targeted-Plasticity in the Corticospinal Tract After Human Spinal Cord Injury.

Authors:  Lasse Christiansen; Monica A Perez
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

3.  Intensive exercise program after spinal cord injury ("Full-On"): study protocol for a randomized controlled trial.

Authors:  Mary P Galea; Sarah A Dunlop; Glen M Davis; Andrew Nunn; Timothy Geraghty; Ya-seng Arthur Hsueh; Leonid Churilov
Journal:  Trials       Date:  2013-09-11       Impact factor: 2.279

4.  Muscle Activation Patterns During Movement Attempts in Children With Acquired Spinal Cord Injury: Neurophysiological Assessment of Residual Motor Function Below the Level of Lesion.

Authors:  Darryn A Atkinson; Laura Mendez; Natalie Goodrich; Sevda C Aslan; Beatrice Ugiliweneza; Andrea L Behrman
Journal:  Front Neurol       Date:  2019-12-20       Impact factor: 4.003

Review 5.  Properties of the surface electromyogram following traumatic spinal cord injury: a scoping review.

Authors:  Gustavo Balbinot; Guijin Li; Matheus Joner Wiest; Maureen Pakosh; Julio Cesar Furlan; Sukhvinder Kalsi-Ryan; Jose Zariffa
Journal:  J Neuroeng Rehabil       Date:  2021-06-29       Impact factor: 4.262

Review 6.  Targeting Lumbar Spinal Neural Circuitry by Epidural Stimulation to Restore Motor Function After Spinal Cord Injury.

Authors:  Karen Minassian; W Barry McKay; Heinrich Binder; Ursula S Hofstoetter
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

7.  Characterization of Spinal Sensorimotor Network Using Transcutaneous Spinal Stimulation during Voluntary Movement Preparation and Performance.

Authors:  Alexander G Steele; Darryn A Atkinson; Blesson Varghese; Jeonghoon Oh; Rachel L Markley; Dimitry G Sayenko
Journal:  J Clin Med       Date:  2021-12-18       Impact factor: 4.964

8.  Prevalence of discomplete sensorimotor spinal cord injury as evidenced by neurophysiological methods: A cross-sectional study.

Authors:  Carl Wahlgren; Richard Levi; Salvador Amezcua; Oumie Thorell; Magnus Thordstein
Journal:  J Rehabil Med       Date:  2021-02-23       Impact factor: 2.912

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.